Bath & Body Works Analyst Ratings
Raymond James Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $37
Bath & Body Works Is Maintained at Outperform by Raymond James
Baird Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $40
Bath & Body Works Analyst Ratings
JP Morgan Maintains Overweight on Bath & Body Works, Lowers Price Target to $41
Bath & Body Works Raised to Overweight From Neutral by Piper Sandler
Bath & Body Works Price Target Cut to $35.00/Share From $38.00 by Piper Sandler
Piper Sandler Upgrades Bath & Body Works(BBWI.US) to Buy Rating, Cuts Target Price to $35
Citi Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $36
Citigroup Maintains Buy on Bath & Body Works, Lowers Price Target to $36
Bath & Body Works Analyst Ratings
Goldman Sachs Maintains Bath & Body Works(BBWI.US) With Buy Rating, Cuts Target Price to $49
BofA Securities Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $45
Bath & Body Works Analyst Ratings
Barclays Maintains Bath & Body Works(BBWI.US) With Hold Rating, Cuts Target Price to $38
TD Cowen Maintains Bath & Body Works(BBWI.US) With Buy Rating, Maintains Target Price $48
Buy Rating Affirmed for Bath & Body Works Amid Strong Financials and Strategic Growth Initiatives
A Quick Look at Today's Ratings for Bath & Body Works(BBWI.US), With a Forecast Between $39 to $50
Bath & Body Works Price Target Raised to $47.00/Share From $45.00 by Baird